Announcement Archives | Global Regulatory Partners

Stay updated with GRP Japan

Filter the latest news by choosing categories below.

- Announcement
- Press Release
2026/08/25
Global Regulatory Partners Announces MHLW Approval of Pegfilgrastim Biosimilar in Japan
Tokyo, Japan – August 25, 2026 – Global Regulatory Partners GK (GRP GK) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) granted marketing approval on August 24, 2026, for Pegfilgrastim BS Subcutaneous Injection 3.6 mg 「GRP」, a pegfilgrastim biosimilar indicated for the prevention of febrile neutropenia associated with cancer chemotherapy.
View More
- Announcement
2026/07/29
Condolences Regarding the “2026 Kumamoto Earthquake”
View More
- Announcement
2026/05/19
Global Regulatory Partners GK Appoints Mariam Davis as Vice President, Japan
View More
- Announcement
2026/04/20
Global Regulatory Partners at Medtec Japan 2026
View More
- Announcement
2026/01/06
News: GRP in Nikkan Kogyo Newspaper Feature on Tokyo Sangyojin
View More
- Announcement
2026/01/06
New Year Message from President & CEO Published
Global Regulatory Partners GK ("GRP") is pleased to announce the publication of our 2026 New Year Message from Dr. Suzan Davis, President & CEO.
View More

Latest News